Cardinal Health raises fiscal 2025 EPS outlook as Q3 non-GAAP EPS rises 13%
Cardinal Health reported third-quarter fiscal 2025 revenue flat at $54.9 billion, while non-GAAP operating earnings rose 21% to $807 million and non-GAAP diluted EPS rose 13% to $2.35. The company raised and narrowed its fiscal 2025 non-GAAP EPS guidance to $8.05 to $8.15, from $7.85 to $8.00, which points to higher expected profit for shareholders.
Key points
- Revenue was flat year over year at $54.9 billion; excluding a previously communicated customer contract expiration, revenue rose 19%.
- Non-GAAP operating earnings rose 21% to $807 million; non-GAAP diluted EPS rose 13% to $2.35.
- GAAP diluted EPS was $2.10, up from $1.07, and GAAP results include $105 million in net litigation recoveries.
- Fiscal 2025 non-GAAP EPS guidance was raised to $8.05 to $8.15, from $7.85 to $8.00; the company plans to discuss fiscal 2026 at an Investor Day on June 12, 2025.
The filing
Written by AI on Nov 8, 2026, 1:42 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 01, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.